Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of phenylacetate in treating children with
recurrent or progressive brain tumors.